Container closure integrity at cryogenic temperatures: how the AT-Closed Vial® ensures safe cryopreservation of novel therapies
November 2020
Scientific paper
What it is about
This white paper looks at how container closure integrity (CCI) holds up when cell and gene therapies are stored frozen, from -80°C down to liquid nitrogen. It explains why conventional stoppered glass vials can lose their seal at cryogenic temperatures, and why standard room-temperature tests may not catch these leaks. Using the AT-Closed Vial® as a case study, it walks through the factors that affect integrity in the cold: material choice, assembly precision and the bond between stopper and vial body. It also reviews test methods suited to cold storage, such as dye ingress, CT scanning and laser headspace analysis.
Why this topic matters
Cell and gene therapies are growing fast, and many have to be frozen at cryogenic temperatures to be stored and shipped. A leaking container can contaminate a sterile, often patient-specific treatment. Standard rubber stoppers can leak while frozen and then reseal once warmed, so routine room-temperature tests may miss the problem. Regulators treat CCI as a critical quality attribute, which makes it a patient-safety issue and not just a packaging detail.